Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework.
Carrara E, Grossi PA, Gori A, Lambertenghi L, Antonelli M, Lombardi A, Bongiovanni F; AIFA-OPERA Working Group; Magrini N, Manfredi C, Stefani S, Tumbarello M, Tacconelli E. Carrara E, et al. Lancet Infect Dis. 2024 Feb;24(2):e113-e126. doi: 10.1016/S1473-3099(23)00435-8. Epub 2023 Sep 4. Lancet Infect Dis. 2024. PMID: 37678308 Review.
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients.
D'Alessandro M, Bennett D, Montagnani F, Cameli P, Perrone A, Bergantini L, Franchi F, Scolletta S, Mazzei MA, Volterrani L, Valente S, Zanelli G, Migliorini L, Rossetti B, Fabbiani M, Vagaggini C, Lanzarone N, Capecchi PL, Cusi MG, Sestini P, Bargagli E, Frediani B; Siena COVID Unit. D'Alessandro M, et al. Minerva Med. 2021 Jun;112(3):423-426. doi: 10.23736/S0026-4806.20.06638-0. Epub 2020 May 14. Minerva Med. 2021. PMID: 32407057 Free article. No abstract available.
Trend over time of HIV-1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).
Rancan I, Cassol C, Graziani L, Tilli M, Malcontenti C, Russo C, Bottanelli M, Bracchitta F, Papaioannu R, Labate L, Mora S, Bezenchek A, Shallvari A, Di Biagio A, Rossetti B. Rancan I, et al. Among authors: cassol c. HIV Med. 2023 Nov;24(11):1150-1157. doi: 10.1111/hiv.13525. Epub 2023 Jul 13. HIV Med. 2023. PMID: 37439411
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019.
Rossetti B, Paglicci L, Di Maio VC, Cassol C, Barbaliscia S, Paolucci S, Bruzzone B, Coppola N, Montagnani F, Micheli V, Monno L, Zanelli G, Santantonio T, Cuomo N, Caudai C, Zazzi M, Ceccherini-Silberstein F, On Behalf Of The Hcv Virology Italian Resistance Network Vironet C. Rossetti B, et al. Among authors: cassol c. Infez Med. 2021 Jun 1;29(2):242-251. Infez Med. 2021. PMID: 34061790 Free article.
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak.
Sambataro G, Giuffrè M, Sambataro D, Palermo A, Vignigni G, Cesareo R, Crimi N, Torrisi SE, Vancheri C, Malatino L, Colaci M, Del Papa N, Pignataro F, Roman-Pognuz E, Fabbiani M, Montagnani F, Cassol C, Cavagna L, Zuccaro V, Zerbato V, Maurel C, Luzzati R, Di Bella S. Sambataro G, et al. Among authors: cassol c. Diagnostics (Basel). 2020 Aug 21;10(9):619. doi: 10.3390/diagnostics10090619. Diagnostics (Basel). 2020. PMID: 32825763 Free PMC article.